Total Payments
$686.93
2023 Payments
$24.38
Companies
7
Transactions
19
Medicare Patients
603
Medicare Billing
$82,346
Payment Breakdown by Category
Food & Beverage$686.93 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $686.93 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $290.51 | 5 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $122.81 | 4 | $0 (2018) |
| The Medicines Company | $78.96 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $75.57 | 1 | $0 (2017) |
| PFIZER INC. | $62.98 | 5 | $0 (2017) |
| Relypsa, Inc. | $31.72 | 2 | $0 (2017) |
| Gilead Sciences, Inc. | $24.38 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $24.38 | 1 | Gilead Sciences, Inc. ($24.38) |
| 2018 | $251.04 | 3 | Otsuka America Pharmaceutical, Inc. ($235.20) |
| 2017 | $411.51 | 15 | Janssen Pharmaceuticals, Inc ($106.97) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2023 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: COVID-19 | ||||||
| 11/27/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $113.09 | General |
| Category: NEPHROLOGY | ||||||
| 06/18/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $122.11 | General |
| Category: NEPHROLOGY | ||||||
| 03/19/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: NEPHROLOGY | ||||||
| 11/30/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Hyperkalemia | ||||||
| 11/29/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/25/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/05/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $69.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/21/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Hyperkalemia | ||||||
| 09/19/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/15/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/07/2017 | The Medicines Company | MINOCIN IV (Drug) | Food and Beverage | In-kind items and services | $78.96 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/07/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: NEPHROLOGY | ||||||
| 07/21/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/20/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/10/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/12/2017 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: NEPHROLOGY | ||||||
| 04/06/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $75.57 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 57 | 71 | $21,780 | $6,699 |
| 2022 | 7 | 163 | 194 | $133,838 | $19,929 |
| 2021 | 7 | 166 | 193 | $72,872 | $22,109 |
| 2020 | 5 | 217 | 241 | $96,940 | $33,610 |
Total Patients
603
Total Services
699
Medicare Billing
$82,346
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 29 | $13,062 | $3,666 | 28.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 18 | $4,518 | $1,640 | 36.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 24 | $4,200 | $1,392 | 33.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 45 | $51,084 | $7,057 | 13.8% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 28 | 29 | $32,226 | $4,133 | 12.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 48 | $11,394 | $2,641 | 23.2% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $15,034 | $2,028 | 13.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 23 | $9,911 | $1,869 | 18.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $10,100 | $1,291 | 12.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 16 | 16 | $4,089 | $910.08 | 22.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 53 | 54 | $20,892 | $7,137 | 34.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 43 | 43 | $19,222 | $6,505 | 33.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 21 | 34 | $11,050 | $2,791 | 25.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 11 | 14 | $9,346 | $2,533 | 27.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 22 | $5,707 | $1,259 | 22.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 15 | 15 | $4,660 | $1,257 | 27.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 11 | 11 | $1,995 | $625.79 | 31.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 124 | 124 | $57,146 | $20,195 | 35.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 35 | 35 | $14,496 | $5,284 | 36.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 13 | 37 | $9,879 | $3,135 | 31.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 24 | 24 | $8,234 | $2,729 | 33.1% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 21 | 21 | $7,185 | $2,267 | 31.5% |
About Murthy Muthuswamy
Murthy Muthuswamy is a Hospitalist healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407065576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Murthy Muthuswamy has received a total of $686.93 in payments from pharmaceutical and medical device companies, with $24.38 received in 2023. These payments were reported across 19 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($686.93).
As a Medicare-enrolled provider, Muthuswamy has provided services to 603 Medicare beneficiaries, totaling 699 services with total Medicare billing of $82,346. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Lafayette, LA
- Active Since 05/22/2007
- Last Updated 01/15/2020
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1407065576
Products in Payments
- SAMSCA (Drug) $177.42
- XARELTO (Drug) $122.81
- JYNARQUE (Drug) $113.09
- ELIQUIS (Drug) $90.43
- MINOCIN IV (Drug) $78.96
- CHANTIX (Drug) $48.12
- Veltassa (Drug) $31.72
- Veklury (Drug) $24.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Lafayette
Dr. May Thomassee, Md, MD
Hospitalist — Payments: $92,953
Hospitalist $92,953
Jean Ancelet, M.d, M.D
Hospitalist — Payments: $8,091
Hospitalist $8,091
Dr. Virasith Rajapho, Md, MD
Hospitalist — Payments: $2,477
Hospitalist $2,477
Shameem Akhtar, M.d, M.D
Hospitalist — Payments: $944.41
Hospitalist $944.41
Dr. Ayodeji Oduola, M.d, M.D
Hospitalist — Payments: $647.59
Hospitalist $647.59
Mohana Neelam, Md, MD
Hospitalist — Payments: $524.01
Hospitalist $524.01